Previous close | 32.53 |
Open | 31.36 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 31.35 - 31.71 |
52-week range | 26.06 - 46.40 |
Volume | |
Avg. volume | 14,103 |
Market cap | 271.78M |
Beta (5Y monthly) | 1.67 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.59 |
Earnings date | 12 Aug 2024 - 16 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 44.00 |
Despite a rise in revenue and strategic advancements, increased losses and operational costs pose hurdles for Sanara MedTech Inc.
Analysis of Financial Performance and Strategic Developments
FORT WORTH, TX, May 13, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today its strategic, operational and financial results for the quarter ended March 31, 2024. R